Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma

Bailey A. Martin‐Giacalone(Washington University in St. Louis), Philip J. Lupo(Emory Healthcare), Stephen X. Skapek(Duke University), Brian D. Crompton(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Javed Khan(Kent State University), Donald A. Barkauskas(University of Southern California), Joshua D. Schiffman(Primary Children's Hospital), Sharon E. Plon(Baylor College of Medicine), Deborah A. Marquez-Do(Baylor College of Medicine), Donna M. Muzny(Baylor College of Medicine), Dana L. Casey(University of North Carolina at Chapel Hill), Corinne M. Linardic(Duke University), Rajkumar Venkatramani(Baylor College of Medicine), Richard A. Gibbs(Baylor College of Medicine), Douglas R. Stewart(Cancer Genetics (United States)), Matthew T. McEvoy(Texas Children's Hospital), Aniko Sabo(Baylor College of Medicine), Shannon Dugan‐Perez(Baylor College of Medicine), Douglas S. Hawkins(Seattle Children's Hospital), David Malkin(University of Toronto), He Li(Baylor College of Medicine), Jack F. Shern(National Institutes of Health), David Hall(Children's Oncology Group), Michael E. Scheurer(Emory University)
JAMA Network Open
March 28, 2024
Cited by 15


Related Papers